Growth Metrics

Pacific Biosciences Of California (PACB) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn -1.44%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.44%
Dec 31, 2025 37.78%
Sep 30, 2025 58.85%
Jun 30, 2025 45.86%
Mar 31, 2025 41.79%
Dec 31, 2024 46.75%
Sep 30, 2024 30.25%
Jun 30, 2024 -30.00%
Mar 31, 2024 20.07%
Dec 31, 2023 4.96%
Sep 30, 2023 -3.37%
Jun 30, 2023 31.08%
Mar 31, 2023 -19.82%
Dec 31, 2022 -91.01%
Jun 30, 2022 -285.46%
Mar 31, 2022 -242.06%
Dec 31, 2021 -122.31%
Jun 30, 2021 33.95%
Mar 31, 2021 -130.66%
Dec 31, 2020 21.55%
Sep 30, 2020 -3.17%
Jun 30, 2020 -35.48%
Mar 31, 2020 397.72%
Dec 31, 2019 4.24%
Sep 30, 2019 -21.76%
Jun 30, 2019 -21.12%
Mar 31, 2019 -34.84%
Dec 31, 2018 6.01%
Sep 30, 2018 20.53%
Jun 30, 2018 -13.18%
Mar 31, 2018 -12.61%
Dec 31, 2017 -56.58%
Sep 30, 2017 -12.36%
Jun 30, 2017 32.17%
Mar 31, 2017 17.74%
Dec 31, 2016 -1,706.86%
Sep 30, 2016 -0.67%
Jun 30, 2016 -152.00%
Mar 31, 2016 15.24%
Dec 31, 2015 95.35%
Sep 30, 2015 -152.93%
Jun 30, 2015 44.98%
Mar 31, 2015 -47.09%
Dec 31, 2014 -5.37%
Sep 30, 2014 -133.30%
Jun 30, 2014 16.99%
Mar 31, 2014 7.50%
Dec 31, 2013 20.02%
Sep 30, 2013 206.09%
Jun 30, 2013 30.51%
Mar 31, 2013 -1.37%
Dec 31, 2012 -23.36%
Sep 30, 2012 26.00%
Jun 30, 2012 23.57%
Mar 31, 2012 48.18%
Dec 31, 2011 62.17%
Sep 30, 2011 28.49%